TNX-4200

N/A

Report date: 2024/07/10 11:08:20
NME

Base Information

Drug NameTNX-4200
Drug Alias NameTNX-4200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte common antigen modulators
TargetsLeukocyte common antigen
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTonix Pharmaceuticals Holding Corp
China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Holding Corp
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A